Basic and escalating immunomodulatory treatments in multiple sclerosis: current therapeutic recommendations.
Details
Serval ID
serval:BIB_82AC98A4A128
Type
Article: article from journal or magazin.
Publication sub-type
Review (review): journal as complete as possible of one specific subject, written based on exhaustive analyses from published work.
Collection
Publications
Institution
Title
Basic and escalating immunomodulatory treatments in multiple sclerosis: current therapeutic recommendations.
Journal
Journal of Neurology
Working group(s)
Multiple Sclerosis Therapy Consensus Group (MSTCG)
Contributor(s)
Baumhackl U., Berger T., Deisenhammer F., Fazekas F., Freimüller M., Kollegger H., Kristoferitsch W., Lassmann H., Markut H., Strasser-Fuchs S., Vass K., Sindic C., D'hooghe MB., Podobnik S., Havrdova E., Elovaara I., Clanet M., Confavreux C., Edan G., Lubetzki C., Altenkirch H., Bamborschke S., Baum K., Bayas A., Benecke R., Brück W., Buttmann M., Chan A., Daumer M., Dommasch D., Elias WG., Fasshauer E., Flachenecker P., Gold R., Haas J., Haferkamp G., Haller P., Hartung HP., Heesen C., Heibel M., Heidenreich F., Hemmer B., Henze T., Hohlfeld R., Janzen RW., Japp G., Jung S., Jügelt E., Kallmann B., Kieseier BC., Kleinschnitz C., Köhler J., Köhler W., Kölmel W., König N., Lehrieder G., Leussink V., Lowitzsch K., Mäurer M., Manegold U., Melms A., Mertin J., Meuth SG., Neuhaus O., Oschmann P., Petereit HF., Pette M., Pöhlau D., Pohl D., Rieckmann P., Ruprecht K., Sailer M., Schipper H., Schmidt S., Schock G., Schulz M., Schwarz S., Schwendemann G., Seidel D., Sommer N., Stangel M., Stark E., Steinbrecher A., Stoll G., Toyka KV., Tumani H., Voltz R., Weber F., Weilbach F., Wiendl H., Wiethölter H., Wildemann B., Zettl UK., Ziemssen T., Zipp F., Zschenderlein R., Orologas A., Guseo A., Bergmann S., Pugliatti M., Myhr KM., Izquierdo G., Bassetti C., Beer K., Beer S., Buettner U., Chofflon M., Gass A., Goebels N., Götschi-Fuchs M., Kappos L., Kesselring K., Ludin HP., Mattle H., Schluep M., Vaney C., Bates D.
ISSN
0340-5354 (Print)
ISSN-L
0340-5354
Publication state
Published
Issued date
2008
Volume
255
Number
10
Pages
1449-1463
Language
english
Notes
Publication types: Consensus Development Conference ; Journal Article ; Practice GuidelinePublication Status: ppublish. M. Schluep fait partie de Multiple Sclerosis Therapy Consensus Group (MSTCG).
Abstract
This review updates and extends earlier Consensus Reports related to current basic and escalating immunomodulatory treatments in multiple sclerosis (MS). The recent literature has been extracted for new evidence from randomized controlled trials, open treatment studies and reported expert opinion, both in original articles and reviews, and evaluates indications and safety issues based on published data. After data extraction from published full length publications and critically weighing the evidence and potential impact of the data, the review has been drafted and circulated within the National MS Societies and the European MS Platform to reach consensus within a very large group of European experts, combining evidence-based criteria and expert opinion where evidence is still incomplete. The review also outlines a few areas of controversy and delineates the need for future research.
Keywords
Antibodies, Monoclonal/adverse effects, Antibodies, Monoclonal/pharmacology, Antibodies, Monoclonal, Humanized, Azathioprine/pharmacology, Azathioprine/therapeutic use, Europe, Health Planning Guidelines, Humans, Immunoglobulins, Intravenous/pharmacology, Immunoglobulins, Intravenous/therapeutic use, Immunologic Factors/administration & dosage, Immunologic Factors/therapeutic use, Interferon-beta/pharmacology, Interferon-beta/therapeutic use, Magnetic Resonance Imaging, Mitoxantrone/pharmacology, Mitoxantrone/therapeutic use, Multiple Sclerosis/diagnosis, Multiple Sclerosis/therapy, Peptides/pharmacology, Peptides/therapeutic use, Plasmapheresis, Randomized Controlled Trials as Topic, Societies/standards
Pubmed
Web of science
Create date
10/02/2010 11:26
Last modification date
20/08/2019 15:42
Usage data
